JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boje, K. M. K.
Right arrow Articles by Lakhman, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boje, K. M. K.
Right arrow Articles by Lakhman, S. S.

Vol. 293, Issue 2, 545-550, May 2000

Nitric Oxide Redox Species Exert Differential Permeability Effects on the Blood-Brain Barrier1

Kathleen M. K. Boje and Sukwinder Singh Lakhman

Department of Pharmaceutics, School of Pharmacy, University of Buffalo, Buffalo, New York

Excessive production of nitric oxide (NO) in the central nervous system is suspected to contribute to neurodegenerative diseases. Previous studies showed that excessive central nervous system NO increased the permeability of the blood-brain barrier (BBB) during experimental meningitis. The present work hypothesizes that the various NO redox forms (NO·, NO+, NO-) differentially mediate disruption of the BBB. Pharmacological agents that release NO redox forms (i.e., NO prodrugs) were selected based on the rate of NO release and the liberated NO redox form. An in situ rodent brain perfusion preparation was used to administer NO prodrugs into the cerebrovascular circulation, followed by brain perfusion with [14C]sucrose, a marker of BBB integrity. Cerebrovasculature infusion of certain NO prodrugs caused a significant, 2- to 5-fold BBB permeability increase in all forebrain regions (P < .01). The NO prodrug rank order of BBB disruption was S-nitroso-N-acetylpenicillamine-beta -cyclodextrin (releases NO·, NO+, and NO-) > Angeli's salt (NO·, NO-) > MAHMA NONOate ~ diethylamine NONOate (NO·) > spermine NONOate (NO·) > DETA NONOate ~ Piloty's acid (negligible NO redox release) ~ saline. When normalized to BBB disruption caused by hyperosmotic mannitol (100%), S-nitroso-N-acetylpenicillamine-beta -cyclodextrin (NO·, NO+, and NO-) elicited ~45% disruption, Angeli's salt (NO·, NO-) elicited ~18% disruption, and the NONOates (NO·) ranged from ~0 to 8% disruption. Cerebral blood flows and intracranial pressures were within normal limits for each tested NO prodrug, thereby suggesting that BBB disruption was not secondary to altered cerebral perfusion. Collectively, the results of this work identify that NO· alone exerts modest BBB disruption compared with the specie combination of NO· and NO-, and the greatest disruption is exerted by the combination of NO·, NO-, and NO+.


1 This study was supported in part by National Institutes of Health Grant NS31939.


0022-3565/00/2932-0545$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
StrokeHome page
S. R. Parathath, I. Gravanis, and S. E. Tsirka
Nitric Oxide Synthase Isoforms Undertake Unique Roles During Excitotoxicity
Stroke, June 1, 2007; 38(6): 1938 - 1945.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
R. C. Brown, K. S. Mark, R. D. Egleton, and T. P. Davis
Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium
Am J Physiol Cell Physiol, May 1, 2004; 286(5): C1045 - C1052.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
A. Minagar and J S. Alexander
Blood-brain barrier disruption in multiple sclerosis
Multiple Sclerosis, December 1, 2003; 9(6): 540 - 549.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. M. K. Boje, D. Jaworowicz Jr., and J. J. Raybon
Neuroinflammatory Role of Prostaglandins during Experimental Meningitis: Evidence Suggestive of an in Vivo Relationship between Nitric Oxide and Prostaglandins
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 319 - 325.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.